Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Non-Current Debt (2016 - 2019)

Historic Non-Current Debt for Forte Biosciences (FBRX) over the last 4 years, with Q2 2019 value amounting to $22.1 million.

  • Forte Biosciences' Non-Current Debt fell 1479.57% to $22.1 million in Q2 2019 from the same period last year, while for Jun 2019 it was $22.1 million, marking a year-over-year decrease of 1479.57%. This contributed to the annual value of $26.2 million for FY2018, which is 62278.62% up from last year.
  • Forte Biosciences' Non-Current Debt amounted to $22.1 million in Q2 2019, which was down 1479.57% from $24.1 million recorded in Q1 2019.
  • In the past 5 years, Forte Biosciences' Non-Current Debt ranged from a high of $26.2 million in Q4 2018 and a low of $2.0 million during Q1 2018
  • Moreover, its 4-year median value for Non-Current Debt was $10.2 million (2016), whereas its average is $14.6 million.
  • Per our database at Business Quant, Forte Biosciences' Non-Current Debt crashed by 7702.44% in 2018 and then skyrocketed by 112408.72% in 2019.
  • Over the past 4 years, Forte Biosciences' Non-Current Debt (Quarter) stood at $10.2 million in 2016, then plummeted by 64.6% to $3.6 million in 2017, then skyrocketed by 622.79% to $26.2 million in 2018, then dropped by 15.73% to $22.1 million in 2019.
  • Its Non-Current Debt stands at $22.1 million for Q2 2019, versus $24.1 million for Q1 2019 and $26.2 million for Q4 2018.